Extremely Robust Esophageal Cancer Pipeline Expected to Change the Pace of Cancer Treatment as Many Critical Pharma Companies are Proactively Participating in Developing Novel Therapies Estimates DelveInsight
October 05, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Extremely Robust Esophageal Cancer Pipeline Expected to Change the Pace of Cancer Treatment as Many Critical Pharma Companies are Proactively...
Global CAR-T Cell Therapy Market Research Report 2021: Approvals of Kymriah and Yescarta in Multiple Regions to Further Push Market Growth
September 21, 2021 04:23 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen; By Indication; By Regions: Segment Forecast, 2021 - 2028"...
DKBinnovative Named to the Prestigious Inc. 5000 List for the 5th Consecutive Year
September 09, 2021 05:00 ET
|
DKBinnovative
FRISCO, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Inc. magazine has ranked DKBinnovative as No. 2,397 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing...
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
September 03, 2021 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary
September 01, 2021 08:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for...
Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
September 01, 2021 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, and The University of Texas...
Imagin Medical Secures New $3 Million Convertible Note Financing
August 26, 2021 16:56 ET
|
Imagin Medical Inc.
Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board.Imagin Medical’s i/Blue™ Imaging...
Risk Strategies Ranks on the Inc. 5000 List, With Three-Year Revenue Growth of 167% Percent
August 17, 2021 09:30 ET
|
Risk Strategies
BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Inc. Magazine today revealed that Risk Strategies, a leading national specialty insurance brokerage and risk management firm, is No. 2374 on its annual Inc....
SecureLink Named One of Inc. 5000’s Fastest-Growing Private Companies in the U.S.
August 17, 2021 07:42 ET
|
SecureLink
AUSTIN, Texas, Aug. 17, 2021 (GLOBE NEWSWIRE) -- SecureLink, a leader in third-party security, ranked 2645 on Inc. Magazine’s 2021 list of the fastest-growing private companies in the United States....
Intel 471 Named to the 2021 Inc. 5000 Annual List of the Fastest-Growing Companies in America
August 17, 2021 07:00 ET
|
Intel 471
LEWES, Del., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Intel 471, the premier provider of cybercrime intelligence for leading intelligence, security, and fraud teams, today revealed that it has earned a...